These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10506883

  • 1. [The pathological/MR tomographic correlation and differential diagnosis of malignant kidney tumors].
    Kreft B, Flacke S, Conrad R, Pauleit D, Bachmann R, Wardelmann E, Albers P, Schild H.
    Rofo; 1999 Aug; 171(2):106-12. PubMed ID: 10506883
    [Abstract] [Full Text] [Related]

  • 2. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A, Gerlach A, Arlart IP, Günes N, Hauser TK, Würstlin S, Bosse A.
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S, Imbriaco M, D'Angelillo M, Mollica C, Camera L, Salvatore M.
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [Abstract] [Full Text] [Related]

  • 4. MR appearance of the pseudocapsule of renal cell carcinoma and its pathologic basis.
    Huang SQ, Zou SS, Huang QL.
    Urol Radiol; 1992 Aug; 13(3):158-61. PubMed ID: 1539405
    [Abstract] [Full Text] [Related]

  • 5. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
    Oliva MR, Glickman JN, Zou KH, Teo SY, Mortelé KJ, Rocha MS, Silverman SG.
    AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
    [Abstract] [Full Text] [Related]

  • 6. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA, Leonardou P, Motohara T, Kanematsu M, Armao D, Semelka RC.
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC, Gudas LJ, Bok D, Rando R, Nanus DM, Tickoo SK.
    Clin Cancer Res; 2003 Oct 15; 9(13):4897-905. PubMed ID: 14581364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
    Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB.
    AJR Am J Roentgenol; 2013 Dec 15; 201(6):1260-7. PubMed ID: 24261365
    [Abstract] [Full Text] [Related]

  • 11. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW.
    J Urol; 2007 Aug 15; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [Abstract] [Full Text] [Related]

  • 12. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T, Yamada K, Kizu O, Hirota T, Ito H, Ishihara K, Nishimura T.
    J Magn Reson Imaging; 2005 Jun 15; 21(6):694-700. PubMed ID: 15906343
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
    Pedrosa I, Alsop DC, Rofsky NM.
    Cancer; 2009 May 15; 115(10 Suppl):2334-45. PubMed ID: 19402070
    [Abstract] [Full Text] [Related]

  • 14. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS, Elmi A, Hosseini-Nik H, Hedgire S, Evans A, Jewett M, Harisinghani M.
    AJR Am J Roentgenol; 2015 Jul 15; 205(1):W79-86. PubMed ID: 26102422
    [Abstract] [Full Text] [Related]

  • 15. Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics.
    Kim SS, Han MH, Kim JE, Lee CH, Chung HW, Lee JS, Chang KH.
    Am J Otolaryngol; 2000 Jul 15; 21(6):366-78. PubMed ID: 11115521
    [Abstract] [Full Text] [Related]

  • 16. [MR imaging features of different renal cell carcinoma subtypes].
    Wu B, Peng WJ, Gu YJ, Yang TX, Jiang ZX, Zhang HL, Dai B, Ye DW, Kong YY, Du X.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):825-30. PubMed ID: 19173827
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Diffusion weighted MR: principles and clinical use in selected brain diseases].
    Nistri M, Mascalchi M, Moretti M, Tessa C, Politi LS, Orlandi I, Pellicanò G, Villari N.
    Radiol Med; 2000 Dec 15; 100(6):470-9. PubMed ID: 11307509
    [Abstract] [Full Text] [Related]

  • 19. Diffusion-weighted MR imaging in the evaluation of renal tumours.
    Squillaci E, Manenti G, Di Stefano F, Miano R, Strigari L, Simonetti G.
    J Exp Clin Cancer Res; 2004 Mar 15; 23(1):39-45. PubMed ID: 15149149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.